title: Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality?
authors.affiliation: School of Public Health and Family Medicine, University of Cape Town.
authors.forename: Andrew
authors.initials: A
authors.lastname: Boulle
authors.forename: Polly
authors.initials: P
authors.lastname: Clayden
authors.forename: Karen
authors.initials: K
authors.lastname: Cohen
authors.forename: Ted
authors.initials: T
authors.lastname: Cohen
authors.forename: Francesca
authors.initials: F
authors.lastname: Conradie
authors.forename: Krista
authors.initials: K
authors.lastname: Dong
authors.forename: Nathan
authors.initials: N
authors.lastname: Geffen
authors.forename: Ashraf
authors.initials: A
authors.lastname: Grimwood
authors.forename: Rocio
authors.initials: R
authors.lastname: Hurtado
authors.forename: Christopher
authors.initials: C
authors.lastname: Kenyon
authors.forename: Stephen
authors.initials: S
authors.lastname: Lawn
authors.forename: Gary
authors.initials: G
authors.lastname: Maartens
authors.forename: Graeme
authors.initials: G
authors.lastname: Meintjes
authors.forename: Marc
authors.initials: M
authors.lastname: Mendelson
authors.forename: Megan
authors.initials: M
authors.lastname: Murray
authors.forename: Molebogeng
authors.initials: M
authors.lastname: Rangaka
authors.forename: Ian
authors.initials: I
authors.lastname: Sanne
authors.forename: David
authors.initials: D
authors.lastname: Spencer
authors.forename: Jantjie
authors.initials: J
authors.lastname: Taljaard
authors.forename: Ebrahim
authors.initials: E
authors.lastname: Variava
authors.forename: W D Francois
authors.initials: WD
authors.lastname: Venter
authors.forename: Douglas
authors.initials: D
authors.lastname: Wilson
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic / Q000941:ethics*; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome; D013019:South Africa / Q000453:epidemiology; D057212:Therapeutic Equipoise; D014376:Tuberculosis / Q000188:drug therapy* / Q000401:mortality
chemical_list: D000900:Anti-Bacterial Agents; D044966:Anti-Retroviral Agents